Entities / Person
Mark Sims.
British astrobiologist
- Reports this week
- 0
- Active events
- 0
- Connections
- 4
What's happening
No events on record for Mark Sims yet.
No events began in the chosen period. Widen it, or reset.
Around Mark Sims this week
News at the entities that move Mark Sims most-
Novartis StructuralNovartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Moves Mark Sims
-
AstraZeneca TransactionalAstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Moves Mark Sims
Connections
The 3 strongest of 4, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Candel Therapeutics Structural
Candel Therapeutics appointed Mark Sims as Chief Commercial Officer.
-
Novartis Structural
Mark Sims was employed by Novartis for a decade.
-
AstraZeneca Transactional
Mark Sims completed an eight-year tenure working at AstraZeneca.